We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
UK Statements delivered on 22 and 23 May 2024 at the WTO General Council in Geneva.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Using an ecological momentary assessment to evaluate your digital health product.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Guidance for manufacturers, importers and distributors.
Documents, certificate, letters, and notes available from the British embassy and consulates in the USA.
Find out what reducing parental conflict is and about the work of the Reducing Parental Conflict Programme.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
How to use a quasi-experimental study to evaluate your digital health product.
A brief explainer of some of the key policy areas of the Prisons Strategy White Paper.
Organisational definitions of terms concerned with risk and risk-related matters.
We’re working to help people securely prove who they are without having to rely on physical documents.
The laws on selling, buying and carrying a knife or weapon depend on the type of knife or weapon, your age and your circumstances.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
How to use a before-and-after study to evaluate your digital health product.
Licensing bodies and collective management organisations can agree licences with users on behalf of owners and collect any royalties the owners are owed.
Information for patients, public and health care professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).